Biosimilars vs. Ustekinumab: What’s the Future of ..

created a new article

1 w - Translate

Biosimilars vs. Ustekinumab: What’s the Future of Biologic Therapies? | # #ustekinumab #biologictherapies #autoimmunedisease #psoriasistreatment #ibdtreatment #crohnsdisease #psoriaticarthritis

Biosimilars vs. Ustekinumab: What’s the Future of Biologic Therapies?

Biosimilars vs. Ustekinumab: What’s the Future of Biologic Therapies?

Primarily used for psoriasis, psoriatic arthritis, and Crohn’s disease, Ustekinumab’s expanding applications are fueling significant growth in its market. The increasing prevalence of chronic inflammatory diseases and the demand for biologic therapies are key drivers shaping the Usteki

Like

Comment

Share